Silverii GA, Marinelli C, Bettarini C, Del Vescovo GG, Monami M, Mannucci E
Every time a vial is accessed the septum punctured and a syringe withdrawn there is a small risk of contamination, and the solution is briefly exposed to air and light
Recognize the maintenance plateau
The glucagon receptor component does not appear to cause significant glucose-raising effects in the context of GLP-1 co-activation, suggesting that the three receptor pathways balance each other in important ways
The time of day doesn't speed up or slow down semaglutide's onset
While taste changes during treatment with GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists are generally benign and self-limiting, certain situations warrant medical evaluation to rule out complications or alternative diagnoses